COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.
Sri Harsha KanuriPrapthi Jayesh SirrkayAyse Sena UlucayPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2023)
Taken together, this review builds upon the current literature of COVID-19-induced A-fib, including pathophysiology, clinical presentation, treatment and complications. Furthermore, it provides recommendations for future research moving forward that can open avenues for developing novel remedies that can prevent as well as hasten clinical recovery of atrial fibrillation in COVID-19 patients.
Keyphrases
- atrial fibrillation
- sars cov
- coronavirus disease
- current status
- oral anticoagulants
- left atrial
- catheter ablation
- heart failure
- left atrial appendage
- direct oral anticoagulants
- systematic review
- respiratory syndrome coronavirus
- percutaneous coronary intervention
- minimally invasive
- risk factors
- combination therapy
- clinical practice
- coronary artery disease
- liver fibrosis
- venous thromboembolism
- endothelial cells